AbbVie (MEX:ABBV) E10: MXN81.10 (As of Mar. 2026)


MEX:ABBV AbbVie Inc MEX:ABBV
72 GF Score
Price MXN4,245.00
GF Value MXN3,691.02
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is AbbVie E10?

AbbVie MEX:ABBV +3.01% 72 E10 is MXN81.10 as of Mar. 2026. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,691.02 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AbbVie's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN7.033. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN81.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, AbbVie's average E10 Growth Rate was -2.10% per year. During the past 3 years, the average E10 Growth Rate was 1.80% per year. During the past 5 years, the average E10 Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of AbbVie was 11.10% per year. The lowest was 1.80% per year. And the median was 6.40% per year.

As of today (2026-06-26), AbbVie's current stock price is MXN4245.00. AbbVie's E10 for the quarter that ended in Mar. 2026 was MXN81.10. AbbVie's Shiller PE Ratio of today is 52.34.

During the past 13 years, the highest Shiller PE Ratio of AbbVie was 51.84. The lowest was 24.95. And the median was 35.68.


AbbVie  (MEX:ABBV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AbbVie's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4245.00/81.10
=52.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of AbbVie was 51.84. The lowest was 24.95. And the median was 35.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AbbVie E10 Related Terms


AbbVie E10 Historical Data

* Premium members only.

The historical data trend for AbbVie's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie E10 Chart

AbbVie Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.15 88.07 76.21 96.53 84.17

AbbVie Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.97 90.82 85.89 84.17 81.10

MEX:ABBV vs MRK, JNJ, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Shiller PE Ratio falls into.


MEX:ABBV
72GF Score
AbbVie Inc MEX:ABBV
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbbVie E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AbbVie's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.033/330.2130*330.2130
=7.033

Current CPI (Mar. 2026) = 330.2130.

AbbVie Quarterly Data

per share eps CPI Adj_EPS
201606 18.124 241.018 24.831
201609 18.755 241.428 25.652
201612 17.524 241.432 23.968
201703 19.959 243.801 27.033
201706 21.510 244.955 28.997
201709 18.329 246.819 24.522
201712 0.589 246.524 0.789
201803 31.612 249.554 41.829
201806 24.758 251.989 32.444
201809 33.856 252.439 44.287
201812 -24.245 251.233 -31.867
201903 32.007 254.202 41.578
201906 9.412 256.143 12.134
201909 24.875 256.759 31.991
201912 35.457 256.974 45.562
202003 47.365 258.115 60.595
202006 -10.618 257.797 -13.601
202009 28.497 260.280 36.154
202012 0.199 260.474 0.252
202103 40.678 264.877 50.712
202106 8.361 271.696 10.162
202109 36.600 274.310 44.059
202112 46.362 278.802 54.911
202203 49.977 287.504 57.401
202206 10.260 296.311 11.434
202209 44.454 296.808 49.457
202212 26.904 296.797 29.933
202303 2.343 301.836 2.563
202306 19.544 305.109 21.152
202309 17.419 307.789 18.688
202312 7.808 306.746 8.405
202403 12.779 312.332 13.511
202406 14.106 314.175 14.826
202409 17.327 315.301 18.146
202412 -0.417 315.605 -0.436
202503 14.730 319.799 15.210
202506 9.791 322.561 10.023
202509 1.834 324.800 1.865
202512 18.366 324.054 18.715
202603 7.033 330.213 7.033

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN81.10 mean?
AbbVie (MEX:ABBV) has a E10 of MXN81.10 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AbbVie and its competitors.
Is AbbVie's E10 too high?
AbbVie's current E10 is MXN81.10. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's E10 compare to MRK and JNJ?
AbbVie's E10 of MXN81.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AbbVie and its competitors. AbbVie's current E10 is MXN81.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,691.02, compared to a current price of MXN4,245.00 — trading 15% above its estimated fair value. The current E10 is MXN81.10. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current E10 is MXN81.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbbVie (MEX:ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of MXN4,245.00 is trading 15% above its estimated GF Value™ of MXN3,691.02. GuruFocus considers AbbVie to be Modestly Overvalued.

Key valuation signals for MEX:ABBV:

  • E10: MXN81.10
  • GF Value™: MXN3,691.02 vs. price of MXN4,245.00 (15% above fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score

Get the complete analysis for MEX:ABBV

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,245.00
Price
MXN3,691.02
GF Value